Resveratrol and resveratrol analogues-structure-activity relationship

Pharmaceutical Research

Volumn 27, Issue 6, 2010, Pages 1042-1048

  Szekeres, Thomas ^a   Fritzer Szekeres, Monika ^a   Saiko, Philipp ^a   Jäger, Walter ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Gallic acid; Resveratrol; Ribonucleotide reductase; Stilbene analogues

Indexed keywords

2,4 DIMETHOXYRESVERATROL; CYCLOOXYGENASE 2; CYTARABINE; DACARBAZINE; DIGALLOYLRESVERATROL; GALLIC ACID; HEXAHYDROXYSTILBENE; MITOGEN ACTIVATED PROTEIN KINASE; PICEATANNOL; RESVERATROL; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; IC 50; IN VIVO STUDY; MELANOMA; METABOLITE; METASTASIS INHIBITION; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; FREE RADICAL SCAVENGERS; HUMANS; NEOPLASMS; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77953230986     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0090-1     Document Type: Review

References (50)

1. JL Richard 1987 Coronary risk factors. The French paradox Arch Mal Coeur Vaiss 80 17 21 3113393
2. A Roldán V Palacios I Caro L Pérez 2003 Resveratrol content of Palomino fino grapes: influence of vintage and fungalinfection J Agric Food Chem 51 1464 1468 10.1021/jf020774u 12590499
3. CR Pace-Asciak S Hahn EP Diamandis G Soleas DM Goldberg 1995 The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease Clin Chim Acta 235 207 219 10.1016/0009-8981(95)06045-1 7554275
4. EN Frankel AL Waterhouse JE Kinsella 1993 Inhibition of human LDL oxidation by resveratrol Lancet 341 1103 1104 10.1016/0140-6736(93)92472-6 8097009
5. AA Bertelli L Giovannini R Stradi A Bertelli JP Tillement 1996 Plasma, urine and tissue levels of trans- and cis-resveratrol (3, 4′, 5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats Int J Tissue React 18 67 71 9063768
6. Y Kimura H Okuda S Arichi 1985 Effects of stilbenes on arachidonate metabolism in leukocytes Biochim Biophys Acta 834 275 278 3922423 (Pubitemid 15072791)
7. GA Potter LH Patterson E Wanogho PJ Perry PC Butler T Ijaz KC Ruparelia JH Lamb PB Farmer LA Stanley MD Burke 2002 The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1 Br J Cancer 86 774 778 10.1038/sj.bjc.6600197 11875742 (Pubitemid 34250822)
8. A Maier-Salamon B Hagenauer M Wirth F Gabor T Szekeres W Jäger 2006 Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites Pharm Res 23 2107 2115 10.1007/s11095-006-9060-z 16952002
9. M Murias M Miksits S Aust M Spatzenegger T Thalhammer T Szekeres W Jaeger 2008 Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition Cancer Lett 261 172 182 10.1016/j.canlet.2007.11.008 18082939
10. AA Bertelli L Giovannini D Giannessi M Migliori W Bernini M Fregoni A Bertelli 1995 Antiplatelet activity of synthetic and natural resveratrol in red wine Int J Tissue React 17 1 3 7499059
11. B Fauconneau P Waffo-Teguo F Huguet L Barrier A Decendit JM Merillon 1997 Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests Life Sci 61 2103 2110 10.1016/S0024-3205(97)00883-7 9395251 (Pubitemid 27478837)
12. M Jang L Cai GO Udeani KV Slowing CF Thomas CW Beecher CW HH Fong NR Farnsworth AD Kinghorn RG Mehta RC Moon JM Pezzuto 1997 Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 218 220 10.1126/science.275.5297.218 8985016
13. M Fontecave M Lepoivre E Elleingand C Gerez O Guittet 1998 Resveratrol, a remarkable inhibitor of ribonucleotide reductase FEBS Lett 421 277 279 10.1016/S0014-5793(97)01572-X 9468322 (Pubitemid 28045770)
14. T Szekeres K Gharehbaghi M Fritzer M Woody A Srivastava B van't Riet, et al. 1994 Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase Cancer Chemother Pharmacol 34 63 66 10.1007/BF00686113 8174204
15. CM Rodrigue N Arous D Bachir J Smith-Ravin PH Romeo F Galacteros MC Garel 2001 Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation Br J Haematol 113 500 507 10.1046/j.1365-2141.2001.02746.x 11380423 (Pubitemid 32523162)
16. BD Gehm JM McAndrews PY Chien JL Jameson 1997 Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor Proc Natl Acad Sci U S A 94 14138 14143 10.1073/pnas.94.25.14138 9391166 (Pubitemid 28009723)
17. PS Ray G Maulik GA Cordis AA Bertelli A Bertelli DK Das 1999 The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury Free Radic Biol Med 27 160 169 10.1016/S0891-5849(99)00063-5 10443932 (Pubitemid 29353096)
18. KT Howitz KJ Bitterman HY Cohen DW Lamming S Lavu JG Wood RE Zipkin P Chung A Kisielewski LL Zhang B Scherer DA Sinclair 2003 Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 191 196 10.1038/nature01960 12939617 (Pubitemid 37150899)
19. JA Baur KJ Pearson NL Price HA Jamieson C Lerin A Kalra VV Prabhu JS Allard G Lopez-Lluch K Lewis PJ Pistell S Poosala KG Becker O Boss D Gwinn M Wang S Ramaswamy KW Fishbein RG Spencer EG Lakatta D Le Couteur RJ Shaw P Navas P Puigserver DK Ingram R de Cabo DA Sinclair 2006 Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 337 342 10.1038/nature05354 17086191 (Pubitemid 44764104)
20. H Yang JA Baur A Chen C Miller JK Adams A Kisielewski KT Howitz RE Zipkin DA Sinclair 2007 Design and synthesis of compounds that extend yeast replicative lifespan Aging Cell 6 35 43 10.1111/j.1474-9726.2006.00259.x 17156081 (Pubitemid 46140138)
21. DM Goldberg J Yan GJ Soleas 2003 Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin Biochem 36 79 87 10.1016/S0009-9120(02)00397-1 12554065 (Pubitemid 36126394)
22. S Das HS Lin PC Ho KY Ng 2008 The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol Pharm Res 25 2593 2600 10.1007/s11095-008-9677-1 18629618
23. NK Narayanan D Nargi C Randolph BA Narayanan 2009 Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice Int J Cancer 125 1 8 10.1002/ijc.24336 19326431
24. S Reagan-Shaw M Nihal N Ahmad 2008 Dose translation from animal to human studies revisited FASEB J 22 659 661 10.1096/fj.07-9574LSF 17942826 (Pubitemid 351348146)
25. M Murias N Handler T Erker K Pleban G Ecker P Saiko T Szekeres W Jäger 2004 Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship Bioorg Med Chem 12 5571 5578 10.1016/j.bmc.2004.08.008 15465334 (Pubitemid 39304056)
26. M Murias W Jäger N Handler T Erker Z Horvath T Szekeres H Nohl L Gille 2005 Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship Biochem Pharmacol 69 903 912 10.1016/j.bcp.2004.12.001 15748702 (Pubitemid 40312708)
27. K Thakkar RL Geahlen M Cushman 1993 Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol J Med Chem 36 2950 2955 10.1021/jm00072a015 8411012 (Pubitemid 23315399)
28. M Rüweler M Gülden E Maser M Murias H Seibert 2009 Cytotoxic, cytoprotective and antioxidant activities of resveratrol and analogues in C6 astroglioma cells in vitro Chem Biol Interact 182 128 135 10.1016/j.cbi.2009.09. 003 19744470
29. KW Lee NJ Kang EA Rogozin SM Oh YS Heo A Pugliese AM Bode HJ Lee Z Dong 2008 The resveratrol analogue 3, 5, 3′, 4′, 5′-pentahydroxy- trans-stilbene inhibits cell transformation via MEK Int J Cancer 123 2487 2496 10.1002/ijc.23830 18767048
30. Z Horvath M Murias P Saiko T Erker N Handler S Madlener, et al. 2006 Cytotoxic and biochemical effects of 3, 3′, 4, 4′, 5, 5′-hexahydroxystilbene, a novel resveratrol analogue in HL-60 human promyelocytic leukemia cells Exp Hematol 34 1377 1384 10.1016/j.exphem.2006.05. 018 16982330 (Pubitemid 44374836)
31. V Wachek Z Horvath S Strommer T Fuereder T Szekeres 2005 Resveratrol analogue M8 chemosensitizes malignant melanoma to dacarbacin in vivo Clin Cancer Res 11 Part 2 Suppl S 8971S
32. Paulitschke V, Schicher N, Szekeres T, Jäger W, Elbling L, Riemer AB, et al. 3,3′,4,4′,5,5′-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model. J Invest Dermatol. Dec 3. [Epubahead of print] 2009.
33. RL Geahlen JL McLaughlin 1989 Piceatannol (3, 4, 3′, 5′-tetrahydroxy-trans-stilbene)is a naturally occurring protein-tyrosine kinase inhibitor Biochem Biophys Res Commun 165 241 245 10.1016/0006-291X(89) 91060-7 2590224 (Pubitemid 20012481)
34. K Ashikawa S Majumdar S Banerjee AC Bharti S Shishodia BB Aggarwal 2002 Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation J Immunol 169 6490 6497 12444159
35. T Wieder A Prokop B Bagci F Essmann D Bernicke K Schulze-Osthoff B Dörken HG Schmalz PT Daniel G Henze 2001 Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts Leukemia 15 1735 1742 11681415
36. M Fritzer-Szekeres I Savinc Z Horvath P Saiko M Pemberger G Graser A Bernhaus M Ozsvar-Kozma M Grusch W Jaeger T Szekeres 2008 Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells-synergism with Ara-C Int J Oncol 33 887 892 18813804
37. M Miksits M Sulyok R Schuhmacher T Szekeres W Jäger 2009 In-vitro sulfation of piceatannol by human liver cytosol and recombinant sulfotransferases J Pharm Pharmacol 61 185 191 10.1211/jpp.61.02.0007 19178765
38. Vo TP, Madlener S, Bago-Horvath Z, Herbacek I, Stark N, Gridling M, et al. Pro- and anti-carcinogenic mechanisms of piceatannol are activated dose-dependently in MCF-7 breast cancer cells. Carcinogenesis. 2009 Aug 20. [Epub ahead of print].
39. Z Horvath P Saiko C Illmer S Madlener T Hoechtl W Bauer, et al. 2005 Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells Exp Hematol 33 329 335 10.1016/j.exphem.2004.11.009 15730856 (Pubitemid 40261314)
40. S Madlener C Illmer Z Horvath P Saiko A Losert I Herbacek M Grusch HL Elford G Krupitza A Bernhaus M Fritzer-Szekeres T Szekeres 2007 Gallic acidinhibits ribonucleotide reductase and cyclooxygenases in human HL-60promyelocytic leukemia cells Cancer Lett 245 156 162 10.1016/j.canlet.2006. 01.001 16488533 (Pubitemid 44959349)
41. A Bernhaus M Fritzer-Szekeres M Grusch P Saiko G Krupitza S Venkateswarlu G Trimurtulu W Jaeger T Szekeres 2009 Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells Cancer Lett 274 299 304 10.1016/j.canlet.2008.09.020 18952370
42. M Cushman D Nagarathnam D Gopal AK Chakraborti CM Lin E Hamel 1991 Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization J Med Chem 34 2579 2588 10.1021/jm00112a036 1875350
43. SH Jeong WS Jo S Song H Suh SY Seol SH Leem TK Kwon YH Yoo 2009 A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells Biochem Pharmacol 77 1337 1347 10.1016/j.bcp.2009.01. 002 19426672
44. BW Moran FP Anderson A Devery S Cloonan WE Butler S Varughese SM Draper PT Kenny 2009 Synthesis, structural characterisation and biological evaluation of fluorinated analogues of resveratrol Bioorg Med Chem 17 4510 4522 10.1016/j.bmc.2009.05.007 19481462
45. YJ Shang YP Qian XD Liu F Dai XL Shang WQ Jia, et al. 2009 Radical-scavenging activity and mechanism of resveratrol-oriented analogues: influence of the solvent, radical, and substitution J Org Chem 74 5025 5031 10.1021/jo9007095 19472994
46. CJ Weng YT Yang CT Ho GC Yen 2009 Mechanisms of apoptotic effects induced by resveratrol, dibenzoylmethane, and their analogues on human lung carcinoma cells J Agric Food Chem 57 5235 5243 10.1021/jf900531m 19441815
47. H Liu A Dong C Gao C Tan H Liu X Zu Y Jiang 2008 The design, synthesis, and anti-tumor mechanism study of N-phosphoryl amino acid modified resveratrol analogues Bioorg Med Chem 16 10013 10021 10.1016/j.bmc.2008.10.022 18952444
48. SS Kang M Cuendet DC Endringer VL Croy JM Pezzuto MA Lipton 2009 Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB Bioorg Med Chem 17 3 1044 1054 10.1016/j.bmc.2008.04.031 18487053
49. JJ Heynekamp WM Weber LA Hunsaker AM Gonzales RA Orlando LM Deck DL Jagt 2006 Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB J Med Chem 49 24 7182 7189 10.1021/jm060630x 17125270 (Pubitemid 44886003)
50. D Simoni M Roberti FP Invidiata E Aiello S Aiello P Marchetti R Baruchello M Eleopra A Di Cristina S Grimaudo N Gebbia L Crosta F Dieli M Tolomeo 2006 Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism Bioorg Med Chem 16 3245 3248 10.1016/j.bmcl.2006.03.028